<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-85799</identifier>
<setSpec>0003-3170</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Cardiovascular risk factors in chronic lower limb ischaemia: the importance of the vascular surgeon</dc:title>
<dc:description xml:lang="en">Objectives. We assess the prevalence of classic cardiovascular risk factors (CVRF) in patientswith chronic lower limb ischaemia (CLLI) on their admission to a Vascular Surgery Unit. Weanalyse their control and treatment at baseline and after the fi rst years of follow up.Material and methods. A retrospective study, including patients with an initial diagnosis of CLLIin 2005-2006. We recorded: CVRF and their treatment, analytical parameters, and cardiovascularevents and treatment after 3-4 years of follow up. Statistical analysis performed were, Studentt, Chi-squared and McNemar tests.Results. The prevalence of active smoking, arterial hypertension, diabetes mellitus and dyslipaemiareferred to by the patients was 45 % (n = 91), 59.4 % (n = 120), 35.6 % (n = 72) and 35.6 % (n = 72)respectively. We diagnosed an additional, three hypertensions, one diabetes and72 hypercholesterolaemias in our baseline study. There was poor blood glucose control (HbA1c &amp;#8805; 7 %)in 60 % of the diabetics. Initially only 42.6 % of patients received antiplatelet or anticoagulanttreatment, 33.7 % (n = 68) statins, and 85 % (n = 102) of hypertensive patients received hypotensivedrugs. After 28.6 ± 11.9 (1-50.3) months, there was a reduction in active smoking to 30.8 % (n = 62)(p &lt; 0.0001), and an increase in antiplatelet or anticoagulant to 96 % (n = 194) (p &lt; 0.0001), statinsto 60,9 % (n = 123) (p &lt; 0.0001) and hypotensives 100 % (n = 123) (p &lt; 0.0001). During this time, 19(9.4 %) had suffered coronary and 13 (6,4 %) cerebrovascular events.Conclusions. The prevalence of CVRF in patients with CLLI is high, often under-diagnosed, andtheir baseline treatment is defi cient. We achieved satisfactory management, although notoptimal, of CVRF in the fi rst years of follow up, basically due to role of the vascular surgeon inthe treatment and secondary prophylaxis of these patients(AU)</dc:description>
<dc:creator>Estallo Laliena, L</dc:creator>
<dc:creator>Izagirre Loroño, M</dc:creator>
<dc:creator>Bravo Ruiz, E</dc:creator>
<dc:creator>Casco Aguilar, C</dc:creator>
<dc:creator>Barba Vélez, Á</dc:creator>
<dc:creator>Vega de Céniga, M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Conclusiones. La prevalencia de FRCV en pacientes con IC-EEII es elevada, frecuentemente infradiagnosticada,y su tratamiento basal es defi ciente. Conseguimos un manejo satisfactorio,aunque no óptimo, de los FRCV en los primeros años de seguimiento, resultando fundamental elpapel del cirujano vascular en el tratamiento y la profi laxis secundaria de estos pacientes(AU)</dc:description>
<dc:source>Angiologia;62(1): 3-8, ene.-feb. 2010. tab</dc:source>
<dc:identifier>ibc-85799</dc:identifier>
<dc:title xml:lang="es">Factores de riesgo cardiovascular en isquemia crónica de extremidades inferiores: importancia de la intervención del cirujano vascular</dc:title>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d^s22073</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d30650^s22067</dc:subject>
<dc:subject>^d2359^s22067</dc:subject>
<dc:subject>^d23925^s22080</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d2359^s22080</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d29897^s22012</dc:subject>
<dc:subject>^d34247^s22067</dc:subject>
<dc:subject>^d962^s22073</dc:subject>
<dc:type>article</dc:type>
<dc:date>201002</dc:date>
</metadata>
</record>
</ibecs-document>
